Cyclerion Therapeutics, Inc. insider was just granted 10,000 options

Terrance Mcguire, an insider of Cyclerion Therapeutics, Inc., just received 10,000 options from the company. The strike price of the options received was $3.97, and these expire on June 24, 2031. Mcguire now owns at least 10,000 options on the company.

Some additional info was provided as follows:


The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Cyclerion Therapeutics, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Current report, items 7.01 and 9.01 - Sept. 30, 2021

Auto Refresh

Feedback